nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
COVID-19 vaccines: the pandemic will not end overnight
|
The Lancet Microbe, |
|
|
2 |
1 |
p. e1 |
artikel |
2 |
Fungal infections in transplant recipients: pros and cons of immunosuppressive and antimicrobial treatment
|
Papon, Nicolas |
|
|
2 |
1 |
p. e6-e8 |
artikel |
3 |
Innovation in wastewater near-source tracking for rapid identification of COVID-19 in schools
|
Hassard, Francis |
|
|
2 |
1 |
p. e4-e5 |
artikel |
4 |
Molecular epidemiology and mortality of group B streptococcal meningitis and infant sepsis in the Netherlands: a 30-year nationwide surveillance study
|
van Kassel, Merel N |
|
|
2 |
1 |
p. e32-e40 |
artikel |
5 |
Progress in tuberculosis vaccine research
|
Venkatesan, Priya |
|
|
2 |
1 |
p. e12 |
artikel |
6 |
SARS-CoV-2, SARS-CoV, and MERS-CoV viral load dynamics, duration of viral shedding, and infectiousness: a systematic review and meta-analysis
|
Cevik, Muge |
|
|
2 |
1 |
p. e13-e22 |
artikel |
7 |
Seroprevalence of chikungunya virus infection in India, 2017: a cross-sectional population-based serosurvey
|
Kumar, Muthusamy Santhosh |
|
|
2 |
1 |
p. e41-e47 |
artikel |
8 |
Viral interference cannot be concluded from datasets containing only symptomatic patients
|
Nordén, Rickard |
|
|
2 |
1 |
p. e9 |
artikel |
9 |
Viral interference cannot be concluded from datasets containing only symptomatic patients – Authors' reply
|
Wu, Anchi |
|
|
2 |
1 |
p. e10 |
artikel |
10 |
WHO's 2021–30 roadmap for neglected tropical diseases
|
Balakrishnan, Vijay Shankar |
|
|
2 |
1 |
p. e11 |
artikel |
11 |
Xenodiagnosis leads the way: elimination of visceral leishmaniasis from the Indian subcontinent is feasible and sustainable
|
Reithinger, Richard |
|
|
2 |
1 |
p. e2-e3 |
artikel |
12 |
Xenodiagnosis to evaluate the infectiousness of humans to sandflies in an area endemic for visceral leishmaniasis in Bihar, India: a transmission-dynamics study
|
Singh, Om Prakash |
|
|
2 |
1 |
p. e23-e31 |
artikel |